Composite endpoints in clinical trials:: the trees and the forest

被引：11

作者：

Ferreira-Gonzalez, Ignacio

Permanyer-Miralda, Gaieta

Busse, Jason W.

Bryant, Dianne M.

Montori, Victor M.

Alonso-Coello, Pablo

Walter, Stephen D.

Guyatt, Gordon H. ^{[1
]}

机构：

[1] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L8, Canada

[2] Hosp Univ Vall Hebron, Serv Cardiol, Unitat Epidemiol, Barcelona, Spain

[3] Autonomous Univ Barcelona, Dept Internal Med, E-08193 Barcelona, Spain

[4] Univ Western Ontario, Fac Hlth Sci, London, ON N6A 3K7, Canada

[5] Mayo Clin & Mayo Fdn, Coll Med, Div Endocrinol Diabet Metab Nutr & Internal Med, Rochester, MN 55905 USA

[6] Hosp Santa Creu & Sant Pau, Dept Clin Epidemiol & Publ Hlth, Iberoamer Cochrane Ctr, Barcelona, Spain

来源：

JOURNAL OF CLINICAL EPIDEMIOLOGY | 2007年 / 60卷 / 07期

关键词：

D O I：

10.1016/j.jclinepi.2006.10.021

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

引用

页码：660 / 661

页数：2

共 11 条

[1] Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial [J].

Dargie, HJ ;

Colucci, Y ;

Ford, I ;

Sendon, JLL ;

Remme, W ;

Sharpe, N ;

Blank, A ;

Holcslaw, TL .

LANCET, 2001, 357 (9266) :1385-1390

[2]

FERREIRAGONZALE.I, 2007, J CLIN EPIDEMIOL

[3] Composite outcomes in randomized trials - Greater precision but with greater uncertainty? [J].

Freemantle, N ;

Calvert, M ;

Wood, J ;

Eastaugh, J ;

Griffin, C .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (19) :2554-2559

[4] Weighing the pros and cons for composite outcomes in clinical trials [J].

Freemantle, Nick ;

Calvert, Melanie .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 2007, 60 (07) :658-659

[5] Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial [J].

Gerstein, H. C. ;

Yusuf, S. ;

Holman, R. R. ;

Bosch, J. ;

Anand, S. ;

Avezum, A. ;

Budaj, A. ;

Chiasson, J. ;

Conget, I. ;

Dagenais, G. ;

Davis, M. ;

Diaz, R. ;

Dinccag, N. ;

Enjalbert, M. ;

Escalante, A. ;

Fodor, G. ;

Hanefeld, M. ;

Hedner, T. ;

Jolly, K. ;

Keltai, M. ;

Laakso, M. ;

Lanas, F. ;

Lonn, E. ;

McQueen, M. ;

Mohan, V. ;

Phillips, A. ;

Piegas, L. ;

Pirags, V. ;

Probstfield, J. ;

Shaw, J. ;

Schmid, I. ;

Teo, K. ;

Zimmet, P. ;

Zinman, B. ;

Gerstein, H. C. ;

Yusuf, S. ;

Bosch, J. ;

Pogue, J. ;

Sheridan, P. ;

Dinccag, N. ;

Hanefeld, M. ;

Hoogwerf, B. ;

Laakso, M. ;

Mohan, V. ;

Shaw, J. ;

Zinman, B. ;

Holman, R. R. ;

Diaz, R. ;

Ahuad Guerrero, R. ;

Albisu, J. .

LANCET, 2006, 368 (9541) :1096-1105

[6] MEASURING HEALTH-RELATED QUALITY-OF-LIFE [J].

GUYATT, GH ;

FEENY, DH ;

PATRICK, DL .

ANNALS OF INTERNAL MEDICINE, 1993, 118 (08) :622-629

[7]

Lewis JA, 1999, STAT MED, V18, P1903, DOI 10.1002/(SICI)1097-0258(19990815)18:15<1903::AID-SIM188>3.3.CO

[8]

2-6

[9]

Moeschberger M L, 1995, Lifetime Data Anal, V1, P195, DOI 10.1007/BF00985770

[10] Validity of composite end points in clinical trials [J].

Montori, VM ;

Permanyer-Miralda, G ;

Ferreira-González, I ;

Busse, JW ;

Pacheco-Huergo, V ;

Bryant, D ;

Alonso, J ;

Akl, EA ;

Domingo-Salvany, A ;

Mills, E ;

Wu, P ;

Schünemann, HJ ;

Jaeschke, R ;

Guyatt, GH .

BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7491) :594-596

← 1 2 →